Healthcare

U.S. Clinical Chemistry and Immunoassay Reagents Markets

 

INDUSTRY
Healthcare

RELEASE DATE
18-Feb-2004
REGION
North America
DELIVERABLE TYPE
Market Research

RESEARCH CODE
A726-01-00-00-00
SKU
HC00952-NA-MR_04805
Yes
SHARE

U.S. Clinical Chemistry and Immunoassay Reagents Markets
Published on: 18-Feb-2004 | SKU: HC00952-NA-MR_04805

Need more details?

$2,450.00

$1,837.50 save 25 %

DownloadLink
Need more details?

Clinical diagnostic tests have long been used as a means of screening, diagnosing, and monitoring disease. Two common methods used in obtaining reportable results for clinical laboratory tests are clinical chemistry and immunoassay techniques. Clinical chemistry tests are analytical human biochemistry tests. Immunoassays, on the other hand, are tests that involve an antigen-antibody reaction. Both types of tests are run using various bodily fluids. It is estimated that over 7.2 billion reportable results were produced in laboratories in the US in 2003, 5.6 billion of which used clinical chemistry and immunoassay techniques and reagents.

Executive Summary

  • Executive Summary

Market Overview

  • Introduction
  • Market Segmentation
  • Market Snapshot
  • Definitions
  • Research Methodology

Market Dynamics

  • Market Challenges
  • Strategies
  • Market Drivers
  • Market Restraints

Unit and Demand Analysis

  • End User Groups
  • Unit and Demand Analysis

Pricing and Revenue Analysis

  • Pricing Analysis
  • Revenue Forecasts

Competitive Landscape and Trends

  • Competitive Structure
  • Market Share Analysis
  • Market and Technology Trends

Market Overview

Unit and Demand Analysis

Pricing and Revenue Analysis

Competitive Environment

Market Overview

Unit and Demand Analysis

Pricing Revenue and Competitive Analysis

Competitive Environment

Frost & Sullivan Awards

Decision Support Databases


Have questions about this research or need deeper insights?
Speak directly with our analytics experts for tailored recommendations.

Recent related Healthcare research

16 Oct 2026   |   Global   |   Market Research

Public Sector Healthcare Cloud Market, North America and Europe, 2026

Public healthcare organizations across North America and Europe are using cloud technologies to support modernization efforts that extend beyond infrastructure replacement. Cloud is increasingly being adopted to improve interoperability, enable secure data sharing, support analytics and AI initiativ...

16 Oct 2026   |   Global   |   Technology Research

Innovations and Growth Opportunities in Precision Therapeutics, AI-Enabled Discovery and Bioengineering, Regenerative Medicine, and Next-Generation Vaccine Platforms

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides a comprehensive overview of breakthrough innovations transforming precision therapeutics, regenerative medicine, AI-enabled discovery, laboratory automation, targeted delivery, vaccines, and biomanufactu...

15 Oct 2026   |   Global   |   Frost Radar

Frost Radar™: US and European Mammalian Contract Development and Manufacturing Organizations, 2026

The US and European mammalian contract development and manufacturing organization (CDMO) market is entering a new phase of strategic evolution, driven by accelerating biologics outsourcing, increasing molecule complexity, and growing demand for resilient, end-to-end manufacturing partnerships. As mo...

08 Oct 2026   |   Global   |   Frost Radar

Frost Radar: Endoscopy Device Technology Ecosystem, 2026

The endoscopy device market is advancing toward higher-quality visualization and improved clinical decision-making, with innovation across 4K ultrahigh-definition display systems, image-enhanced endoscopy, and computer-aided detection systems. Advanced visualization is evolving through improvements ...

07 Oct 2026   |   Global   |   Technology Research

Growth Opportunities in Image-Guided Cancer Ablation Systems

Image-guided cancer ablation systems are minimally invasive medical technologies that use real-time imaging to accurately guide the placement of an ablation device into a tumor, enabling localized destruction of cancerous tissue while minimizing damage to surrounding healthy structures.The increasin...

 

Purchase includes:
  • Report download
  • Growth Dialog™ with our experts

Growth Dialog™

A tailored session with you where we identify the:
  • Strategic Imperatives
  • Growth Opportunities
  • Best Practices
  • Companies to Action

Impacting your company's future growth potential.